Cargando…

Differential Iron Requirements for Osteoblast and Adipocyte Differentiation

Bone marrow mesenchymal progenitor cells are precursors for various cell types including osteoblasts, adipocytes, and chondrocytes. The external environment and signals act to direct the pathway of differentiation. Importantly, situations such as aging and chronic kidney disease display alterations...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Daniel F., Miller, Christopher J., Quintana‐Martinez, Arelis, Wright, Christian S., Prideaux, Matthew, Atkins, Gerald J., Thompson, William R., Clinkenbeard, Erica L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441506/
https://www.ncbi.nlm.nih.gov/pubmed/34532614
http://dx.doi.org/10.1002/jbm4.10529
_version_ 1783752882651136000
author Edwards, Daniel F.
Miller, Christopher J.
Quintana‐Martinez, Arelis
Wright, Christian S.
Prideaux, Matthew
Atkins, Gerald J.
Thompson, William R.
Clinkenbeard, Erica L.
author_facet Edwards, Daniel F.
Miller, Christopher J.
Quintana‐Martinez, Arelis
Wright, Christian S.
Prideaux, Matthew
Atkins, Gerald J.
Thompson, William R.
Clinkenbeard, Erica L.
author_sort Edwards, Daniel F.
collection PubMed
description Bone marrow mesenchymal progenitor cells are precursors for various cell types including osteoblasts, adipocytes, and chondrocytes. The external environment and signals act to direct the pathway of differentiation. Importantly, situations such as aging and chronic kidney disease display alterations in the balance of osteoblast and adipocyte differentiation, adversely affecting bone integrity. Iron deficiency, which can often occur during aging and chronic kidney disease, is associated with reduced bone density. The purpose of this study was to assess the effects of iron deficiency on the capacity of progenitor cell differentiation pathways. Mouse and human progenitor cells, differentiated under standard osteoblast and adipocyte protocols in the presence of the iron chelator deferoxamine (DFO), were used. Under osteogenic conditions, 5μM DFO significantly impaired expression of critical osteoblast genes, including osteocalcin, type 1 collagen, and dentin matrix protein 1. This led to a reduction in alkaline phosphatase activity and impaired mineralization. Despite prolonged exposure to chronic iron deficiency, cells retained viability as well as normal hypoxic responses with significant increases in transferrin receptor and protein accumulation of hypoxia inducible factor 1α. Similar concentrations of DFO were used when cells were maintained in adipogenic conditions. In contrast to osteoblast differentiation, DFO modestly suppressed adipocyte gene expression of peroxisome‐proliferating activated receptor gamma, lipoprotein lipase, and adiponectin at earlier time points with normalization at later stages. Lipid accumulation was also similar in all conditions. These data suggest the critical importance of iron in osteoblast differentiation, and as long as the external stimuli are present, iron deficiency does not impede adipogenesis. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
format Online
Article
Text
id pubmed-8441506
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-84415062021-09-15 Differential Iron Requirements for Osteoblast and Adipocyte Differentiation Edwards, Daniel F. Miller, Christopher J. Quintana‐Martinez, Arelis Wright, Christian S. Prideaux, Matthew Atkins, Gerald J. Thompson, William R. Clinkenbeard, Erica L. JBMR Plus Original Articles Bone marrow mesenchymal progenitor cells are precursors for various cell types including osteoblasts, adipocytes, and chondrocytes. The external environment and signals act to direct the pathway of differentiation. Importantly, situations such as aging and chronic kidney disease display alterations in the balance of osteoblast and adipocyte differentiation, adversely affecting bone integrity. Iron deficiency, which can often occur during aging and chronic kidney disease, is associated with reduced bone density. The purpose of this study was to assess the effects of iron deficiency on the capacity of progenitor cell differentiation pathways. Mouse and human progenitor cells, differentiated under standard osteoblast and adipocyte protocols in the presence of the iron chelator deferoxamine (DFO), were used. Under osteogenic conditions, 5μM DFO significantly impaired expression of critical osteoblast genes, including osteocalcin, type 1 collagen, and dentin matrix protein 1. This led to a reduction in alkaline phosphatase activity and impaired mineralization. Despite prolonged exposure to chronic iron deficiency, cells retained viability as well as normal hypoxic responses with significant increases in transferrin receptor and protein accumulation of hypoxia inducible factor 1α. Similar concentrations of DFO were used when cells were maintained in adipogenic conditions. In contrast to osteoblast differentiation, DFO modestly suppressed adipocyte gene expression of peroxisome‐proliferating activated receptor gamma, lipoprotein lipase, and adiponectin at earlier time points with normalization at later stages. Lipid accumulation was also similar in all conditions. These data suggest the critical importance of iron in osteoblast differentiation, and as long as the external stimuli are present, iron deficiency does not impede adipogenesis. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. John Wiley & Sons, Inc. 2021-07-26 /pmc/articles/PMC8441506/ /pubmed/34532614 http://dx.doi.org/10.1002/jbm4.10529 Text en © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Edwards, Daniel F.
Miller, Christopher J.
Quintana‐Martinez, Arelis
Wright, Christian S.
Prideaux, Matthew
Atkins, Gerald J.
Thompson, William R.
Clinkenbeard, Erica L.
Differential Iron Requirements for Osteoblast and Adipocyte Differentiation
title Differential Iron Requirements for Osteoblast and Adipocyte Differentiation
title_full Differential Iron Requirements for Osteoblast and Adipocyte Differentiation
title_fullStr Differential Iron Requirements for Osteoblast and Adipocyte Differentiation
title_full_unstemmed Differential Iron Requirements for Osteoblast and Adipocyte Differentiation
title_short Differential Iron Requirements for Osteoblast and Adipocyte Differentiation
title_sort differential iron requirements for osteoblast and adipocyte differentiation
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441506/
https://www.ncbi.nlm.nih.gov/pubmed/34532614
http://dx.doi.org/10.1002/jbm4.10529
work_keys_str_mv AT edwardsdanielf differentialironrequirementsforosteoblastandadipocytedifferentiation
AT millerchristopherj differentialironrequirementsforosteoblastandadipocytedifferentiation
AT quintanamartinezarelis differentialironrequirementsforosteoblastandadipocytedifferentiation
AT wrightchristians differentialironrequirementsforosteoblastandadipocytedifferentiation
AT prideauxmatthew differentialironrequirementsforosteoblastandadipocytedifferentiation
AT atkinsgeraldj differentialironrequirementsforosteoblastandadipocytedifferentiation
AT thompsonwilliamr differentialironrequirementsforosteoblastandadipocytedifferentiation
AT clinkenbearderical differentialironrequirementsforosteoblastandadipocytedifferentiation